Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-09-09 Purchase |
2024-09-11 5:47 pm |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
140,000 | $2.8222 | $395,115 | 384,024 (Direct) |
View |
2024-01-29 Purchase |
2024-01-31 6:29 pm |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
100,000 | $3.8674 | $386,738 | 244,024 (Direct) |
View |
2022-12-08 Purchase |
2022-12-12 8:00 pm |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
55,250 | $2.096 | $115,804 | 144,024 (Direct) |
View |
2022-06-30 Sale |
2022-07-05 4:30 pm |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
29,767 | $18.8 | $559,577 | 102,529 (Direct) |
View |
2021-03-09 Sale |
2021-03-11 5:51 pm |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
10,000 | $35.48 | $354,845 | 187,985 (Direct) |
View |
2021-02-24 Sale |
2021-02-26 4:50 pm |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
10,000 | $34.24 | $342,392 | 197,985 (Direct) |
View |
2021-02-11 Sale |
2021-02-16 5:10 pm |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
1,446 | $35.43 | $51,238 | 207,985 (Direct) |
View |
2021-02-08 Sale |
2021-02-10 7:25 pm |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
11,206 | $35.17 | $394,085 | 209,431 (Direct) |
View |
2021-02-02 Sale |
2021-02-04 5:40 pm |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
3,278 | $35.07 | $114,970 | 234,018 (Direct) |
View |
2021-01-27 Sale |
2021-01-29 5:22 pm |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
10,000 | $32.39 | $323,914 | 223,915 (Direct) |
View |
2021-01-22 Sale |
2021-01-26 7:29 pm |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
4,070 | $35.43 | $144,180 | 233,915 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-05-24 Other |
2024-05-29 9:25 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
122,358 | $0 | 490,120 (Direct) |
View |
2024-05-24 Option Award |
2024-05-29 9:25 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
122,358 | $0 | 490,120 (Direct) |
View |
2023-12-15 Option Award |
2023-12-19 5:28 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
183,881 | $0 | 183,881 (Direct) |
View |
2023-05-25 Option Award |
2023-05-30 5:10 pm |
2022-12-16 2032-12-16 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
527,211 | $0 | 850,728 (Direct) |
View |
2021-07-08 Ownership(A) |
2023-02-06 5:39 pm |
N/A 2022-07-10 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
351,985 | $0 | 777,934 (Direct) |
View |
2021-07-08 Ownership |
2023-02-02 5:01 pm |
N/A 2022-07-10 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
351,985 | $0 | 552,934 (Direct) |
View |
2022-12-16 Other |
2022-12-20 7:31 pm |
N/A 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
300,000 | $0 | 0 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 5:34 pm |
2022-12-16 2032-12-16 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
323,517 | $0 | 323,517 (Direct) |
View |
2022-06-30 Exercise |
2022-07-05 4:30 pm |
2012-07-10 2022-07-10 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
29,767 | $0 | 102,529 (Direct) |
View |
2022-06-30 Exercise |
2022-07-05 4:30 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
29,767 | $16 | 102,529 (Direct) |
View |
2022-05-25 Option Award |
2022-05-26 6:45 pm |
2022-03-17 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
951,821 | $0 | 1,443,994 (Direct) |
View |
2021-12-17 Option Award |
2021-12-21 9:31 pm |
2022-03-17 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
492,173 | $0 | 492,173 (Direct) |
View |
2021-03-09 Exercise |
2021-03-11 5:51 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
10,000 | $3.24 | 187,985 (Direct) |
View |
2021-03-09 Exercise |
2021-03-11 5:51 pm |
2017-10-20 2027-10-20 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
10,000 | $0 | 187,985 (Direct) |
View |
2021-02-24 Exercise |
2021-02-26 4:50 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
10,000 | $3.24 | 197,985 (Direct) |
View |
2021-02-24 Exercise |
2021-02-26 4:50 pm |
2017-10-20 2027-10-20 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
10,000 | $0 | 197,985 (Direct) |
View |
2021-02-11 Exercise |
2021-02-16 5:10 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
1,446 | $3.24 | 207,985 (Direct) |
View |
2021-02-11 Exercise |
2021-02-16 5:10 pm |
2017-10-20 2027-10-20 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
1,446 | $0 | 207,985 (Direct) |
View |
2021-02-08 Exercise |
2021-02-10 7:25 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
11,206 | $3.24 | 209,431 (Direct) |
View |
2021-02-08 Exercise |
2021-02-10 7:25 pm |
2017-10-20 2027-10-20 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
11,206 | $0 | 209,431 (Direct) |
View |
2021-02-02 Exercise |
2021-02-04 5:42 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
13,281 | $3.24 | 220,637 (Direct) |
View |
2021-02-02 Exercise |
2021-02-04 5:42 pm |
2017-10-20 2027-10-20 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
13,281 | $0 | 220,637 (Direct) |
View |
2021-02-02 Exercise |
2021-02-04 5:40 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
3,278 | $3.24 | 234,018 (Direct) |
View |
2021-02-02 Exercise |
2021-02-04 5:40 pm |
2017-10-20 2027-10-20 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
3,278 | $0 | 234,018 (Direct) |
View |
2021-01-27 Exercise |
2021-01-29 5:22 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
10,000 | $3.24 | 223,915 (Direct) |
View |
2021-01-27 Exercise |
2021-01-29 5:22 pm |
2017-10-20 2027-10-20 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
10,000 | $0 | 223,915 (Direct) |
View |
2021-01-22 Exercise |
2021-01-26 7:29 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
4,070 | $3.24 | 233,915 (Direct) |
View |
2021-01-22 Exercise |
2021-01-26 7:29 pm |
2017-10-20 2027-10-20 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
4,070 | $0 | 233,915 (Direct) |
View |
2021-01-07 Option Award |
2021-01-11 4:05 pm |
2021-04-07 2031-01-07 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
500,000 | $0 | 500,000 (Direct) |
View |
2020-08-18 Exercise |
2020-08-19 4:15 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
50,008 | $3.24 | 237,985 (Direct) |
View |
2020-08-18 Exercise |
2020-08-19 4:15 pm |
2017-10-20 2027-10-20 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
50,008 | $0 | 237,985 (Direct) |
View |
2020-08-18 Tax Withholding |
2020-08-19 4:15 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
4,151 | $39.03 | 237,985 (Direct) |
View |